Mumbai: Global pharma major, Lupin Limited, has received approval from the United States Food and Drug Administration (U.S.

Shares of Syngene International Ltd. tumbled 10% on Thursday, April 24, 2025 as the company announced 3% year-on-year decline in consolidated net profit to Rs 183 crore for Q4 FY25, down from Rs 189 ...